{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:38:44Z","timestamp":1777430324304,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Candida<\/jats:italic>\n                      bloodstream infection (BSI) causes appreciable mortality in neonates and children. There are few studies describing the epidemiology of\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI in children living in sub-Saharan Africa.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective descriptive study was conducted at three public sector hospitals in Cape Town, South Africa. Demographic and clinical details, antifungal management and patient outcome data were obtained by medical record review.\n                      <jats:italic>Candida<\/jats:italic>\n                      species distribution and antifungal susceptibility testing results were obtained from the National Health Laboratory Service database.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 97\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI episodes identified during a five-year period, 48\/97 (49%) were\n                      <jats:italic>Candida albicans (C. albicans)<\/jats:italic>\n                      , and 49\/97 (51%) were non-\n                      <jats:italic>C. albicans<\/jats:italic>\n                      species. The overall incidence risk was 0.8\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI episodes per 1000 admissions at Red Cross War Memorial Children\u2019s Hospital. Of the 77\/97 (79%)\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI episodes with available clinical information, the median age (interquartile range) at the time of BSI was 7 (1\u201325) months, 36\/77 (47%) were associated with moderate or severe underweight-for-age and vasopressor therapy was administered to 22\/77 (29%) study participants. Most of the\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI episodes were healthcare-associated infections, 63\/77 (82%). Fluconazole resistance was documented among 17%, 0% and 0% of\n                      <jats:italic>C. parapsilosis, C. tropicalis<\/jats:italic>\n                      and\n                      <jats:italic>C. albicans<\/jats:italic>\n                      isolates, respectively. All\n                      <jats:italic>Candida<\/jats:italic>\n                      isolates tested were susceptible to amphotericin B and the echinocandins. The mortality rate within 30\u00a0days of\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI diagnosis was 13\/75 (17%). On multivariable analysis, factors associated with mortality within 30\u00a0days of\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI diagnosis included vasopressor therapy requirement during\n                      <jats:italic>Candida<\/jats:italic>\n                      BSI, adjusted Odds ratio (aOR) 53 (95% confidence interval 2\u20131029); hepatic dysfunction, aOR 13 (95% CI 1\u2013146); and concomitant bacterial BSI, aOR 10 (95% CI 2\u201360).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The study adds to the limited number of studies describing paediatric\u00a0\n                      <jats:italic>Candida<\/jats:italic>\n                      \u00a0BSI in sub-Saharan Africa. Non-\n                      <jats:italic>C. Albicans<\/jats:italic>\n                      BSI episodes occurred more frequently than\n                      <jats:italic>C. albicans<\/jats:italic>\n                      episodes, and vasopressor therapy requirement, hepatic dysfunction and concomitant bacterial BSI were associated with an increase in 30-day mortality.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08027-z","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T05:03:21Z","timestamp":1675400601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Candida bloodstream infection among children hospitalised in three public-sector hospitals in the Metro West region of Cape Town, South Africa"],"prefix":"10.1186","volume":"23","author":[{"given":"Mulugeta Naizgi","family":"Gebremicael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J. C.","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsah D.","family":"Tootla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Khumalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Tooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamiel","family":"Salie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudzani","family":"Muloiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Rhoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wisdom","family":"Basera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S.","family":"Eley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"issue":"5","key":"8027_CR1","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1542\/peds.2008-2055","volume":"123","author":"CC Blyth","year":"2009","unstructured":"Blyth CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatr. 2009;123(5):1360\u20138. https:\/\/doi.org\/10.1542\/peds.2008-2055.","journal-title":"Pediatr"},{"issue":"12","key":"8027_CR2","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1007\/s00134-013-3057-y","volume":"39","author":"L Vogiatzi","year":"2013","unstructured":"Vogiatzi L, Ilia S, Sideri G, Vagelakoudi E, Vassilopoulou M, Sdougka M, et al. Invasive candidiasis in pediatric intensive care in Greece: a nationwide study. Intensive Care Med. 2013;39(12):2188\u201395. https:\/\/doi.org\/10.1007\/s00134-013-3057-y.","journal-title":"Intensive Care Med"},{"issue":"8","key":"8027_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/INF.0000000000003151","volume":"40","author":"L Shuping","year":"2021","unstructured":"Shuping L, Mpembe R, Mhlanga M, Naicker SD, Maphanga TG, Tsotetsi E, et al. Epidemiology of culture-confirmed candidemia among hospitalized children in South Africa, 2012\u20132017. Pediatr Infect Dis J. 2021;40(8):730\u20137. https:\/\/doi.org\/10.1097\/INF.0000000000003151.","journal-title":"Pediatr Infect Dis J"},{"key":"8027_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1186\/s12879-017-2862-2","volume":"17","author":"H Lochan","year":"2017","unstructured":"Lochan H, Pillay V, Bamford C, Nuttall J, Eley B. Bloodstream infections at a tertiary level paediatric hospital in South Africa. BMC Infect Dis. 2017;17:750. https:\/\/doi.org\/10.1186\/s12879-017-2862-2.","journal-title":"BMC Infect Dis"},{"key":"8027_CR5","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.2147\/IDR.S196972","volume":"12","author":"SM Khairat","year":"2019","unstructured":"Khairat SM, Sayed AM, Nabih M, Soliman NS, Hassan YM. Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility. Infect Drug Resist. 2019;12:2409\u201316. https:\/\/doi.org\/10.2147\/IDR.S196972.","journal-title":"Infect Drug Resist"},{"issue":"Suppl 1","key":"8027_CR6","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/jac\/dki218","volume":"56","author":"MD Richardson","year":"2005","unstructured":"Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother. 2005;56(Suppl 1):i5\u201311. https:\/\/doi.org\/10.1093\/jac\/dki218.","journal-title":"J Antimicrob Chemother."},{"issue":"2","key":"8027_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1099\/0022-1317-51-2-110","volume":"51","author":"V Krcmery","year":"2002","unstructured":"Krcmery V, Laho L, Huttova M, Ondrusova A, Kralinsky K, Pevalova L, et al. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia. J Med Microbiol. 2002;51(2):110\u20136. https:\/\/doi.org\/10.1099\/0022-1317-51-2-110.","journal-title":"J Med Microbiol"},{"issue":"2","key":"8027_CR8","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/INF.0000000000000039","volume":"33","author":"ME Santolaya","year":"2014","unstructured":"Santolaya ME, Alvarado T, Queiroz-Telles F, Colombo AL, Zurita J, Tiraboschi IN, et al. Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome. Pediatr Infect Dis J. 2014;33(2):e40\u20134. https:\/\/doi.org\/10.1097\/INF.0000000000000039.","journal-title":"Pediatr Infect Dis J"},{"key":"8027_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12879-018-3100-2","volume":"18","author":"JF Hsu","year":"2018","unstructured":"Hsu JF, Lai MY, Lee CW, Chu SM, Wu IH, Huang HR, et al. Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates. BMC Infect Dis. 2018;18:194. https:\/\/doi.org\/10.1186\/s12879-018-3100-2.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"8027_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/mmy\/myv060","volume":"53","author":"X Ding","year":"2015","unstructured":"Ding X, Yan D, Sun W, Zeng Z, Su R, Su J. Epidemiology, and risk factors for nosocomial non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med Mycol. 2015;53(7):684\u201390. https:\/\/doi.org\/10.1093\/mmy\/myv060.","journal-title":"Med Mycol"},{"key":"8027_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijid.2013.11.011","volume":"22","author":"Z Wu","year":"2014","unstructured":"Wu Z, Liu Y, Feng X, Liu Y, Wang S, Zhu X, et al. Candidemia: incidence rates, type of species, and risk factors at a tertiary care academic hospital in China. Int J Infect Dis. 2014;22:4\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2013.11.011.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"8027_CR12","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1128\/JCM.44.5.1782-1787.2006","volume":"44","author":"SA Messer","year":"2006","unstructured":"Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol. 2006;44(5):1782\u20137. https:\/\/doi.org\/10.1128\/JCM.44.5.1782-1787.2006.","journal-title":"J Clin Microbiol."},{"issue":"1","key":"8027_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133\u201363. https:\/\/doi.org\/10.1128\/CMR.00029-06.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"8027_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.ajic.2016.03.026","volume":"44","author":"J Fu","year":"2016","unstructured":"Fu J, Wang X, Wei B, Jiang Y, Chen J. Risk factors and clinical analysis of candidemia in very-low-birth-weight neonates. Am J Infect Control. 2016;44(11):1321\u20135. https:\/\/doi.org\/10.1016\/j.ajic.2016.03.026.","journal-title":"Am J Infect Control"},{"issue":"6","key":"8027_CR15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/tropej\/fmt053","volume":"59","author":"DE Ballot","year":"2013","unstructured":"Ballot DE, Bosman N, Nana T, Ramdin T, Cooper PA. Background changing patterns of neonatal fungal sepsis in a developing country. J Trop Pediatr. 2013;59(6):460\u20134. https:\/\/doi.org\/10.1093\/tropej\/fmt053.","journal-title":"J Trop Pediatr"},{"issue":"5","key":"8027_CR16","first-page":"489","volume":"53","author":"N Belet","year":"2011","unstructured":"Belet N, Cift\u00e7i E, Aysev D, Guriz H, Uysal Z, Tacyildiz N, et al. Invasive Candida infections in children: the clinical characteristics and species distribution and antifungal susceptibility of Candida spp. Turk J Pediatr. 2011;53(5):489\u201398.","journal-title":"Turk J Pediatr"},{"key":"8027_CR17","unstructured":"Clinical and Laboratory Standards Institute (CSLI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. CLSI document M27-S4. (ISBN 1-56238-860-0 [Print]; ISSN 1-56238-864-9 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania. 19087 USA, 2012."},{"key":"8027_CR18","unstructured":"National Healthcare Safety Newtwork. Identifying Healthcare-associated Infections (HAI) for NHSN Surveillance. 2022:2.1-2.29. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/2psc_identifyinghais_nhsncurrent.pdf."},{"issue":"RR10","key":"8027_CR19","first-page":"1","volume":"57","author":"E Schneider","year":"2008","unstructured":"Schneider E, Whitmore S, Glynn MK, Dominguez K, Mitsch A, McKenna MT, et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years\u2014United States, 2008. MMWR Recomm Rep. 2008;57(RR10):1\u201312.","journal-title":"MMWR Recomm Rep"},{"key":"8027_CR20","unstructured":"World Health Organization. Child growth standards, 2006. https:\/\/www.who.int\/tools\/child-growth-standards. Accessed 7 July 2019."},{"issue":"2","key":"8027_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00006454-199702000-00005","volume":"16","author":"JR Phillips","year":"1997","unstructured":"Phillips JR, Karlowitz MG. Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr Infect Dis J. 1997;16(2):190\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"8027_CR22","doi-asserted-by":"publisher","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opel SM, et al. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2013;39(2):165\u2013228. doi: https:\/\/doi.org\/10.1007\/s00134-012-2769-8.","DOI":"10.1007\/s00134-012-2769-8"},{"issue":"10","key":"8027_CR23","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s00467-010-1533-y","volume":"25","author":"DP Boer","year":"2010","unstructured":"Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol. 2010;25(10):2107\u201313. https:\/\/doi.org\/10.1007\/s00467-010-1533-y.","journal-title":"Pediatr Nephrol"},{"issue":"1\u20132","key":"8027_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cca.2008.06.017","volume":"396","author":"H Pottel","year":"2008","unstructured":"Pottel H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F. Establishing age\/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta. 2008;396(1\u20132):49\u201355. https:\/\/doi.org\/10.1016\/j.cca.2008.06.017.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"8027_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A. International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2\u20138. https:\/\/doi.org\/10.1097\/01.PCC.0000149131.","journal-title":"Pediatr Crit Care Med."},{"issue":"3","key":"8027_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jof3030041","volume":"3","author":"H Kaur","year":"2017","unstructured":"Kaur H, Chakrabarti A. Strategies to reduce mortality in adult and neonatal candidemia in developing countries. J Fungi (Basel). 2017;3(3):41. https:\/\/doi.org\/10.3390\/jof3030041.","journal-title":"J Fungi (Basel)"},{"issue":"7","key":"8027_CR27","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3201\/eid2407.171087","volume":"24","author":"E van Schalkwyk","year":"2018","unstructured":"van Schalkwyk E, Iyaloo S, Naicker SD, Maphanga TG, Mbembe RS, Zulu TG, et al. Large outbreaks of fungal and bacterial bloodstream infections in a Neonatal Unit, South Africa, 2012\u20132016. Emerg Infect Dis. 2018;24(7):1204\u201312. https:\/\/doi.org\/10.3201\/eid2407.171087.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"8027_CR28","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/cncr.23466","volume":"112","author":"R Hachem","year":"2008","unstructured":"Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer. 2008;112(11):2493\u20139. https:\/\/doi.org\/10.1002\/cncr.23466.","journal-title":"Cancer"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08027-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08027-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08027-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T05:03:55Z","timestamp":1675400635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08027-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8027"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08027-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2203629\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"assertion":[{"value":"25 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Human Research Ethics Committee (HREC), Faculty of Health Sciences, University of Cape Town, reference number: HREC REF 159\/2020 and the RCWMCH research committee. Furthermore, the study was completed in accordance with the Declaration of Helsinki. Since the data was collected retrospectively, the HREC waived the need for informed consent. Patient details were anonymised before data analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}